An Introduction to the \u27Oceans and Society: Blue Planet\u27 Initiative

We live on a blue planet, and Earth’s waters benefit many sectors of society. The future of our blue planet is increasingly reliant on the services delivered by marine, coastal and inland waters and on the advancement of effective, evidence-based decisions on sustainable development. ‘Oceans and Society: Blue Planet’ is an initiative of the Group on Earth Observations (GEO) that aims to ensure the sustained development and use of ocean and coastal observations for the benefit of society. The initiative works to advance and exploit synergies among the many observational programmes devoted to ocean and coastal waters; to improve engagement with a variety of stakeholders for enhancing the timeliness, quality and range of information delivered; and to raise awareness of the societal benefits of ocean observations at the public and policy levels. This paper summarises the role of the initiative, current activities and considerations for future directions

Nano-chromium picolinate and heat stress enhance insulin sensitivity in cross-bred sheep

This study evaluated the effects of heat stress (HS) and dietary nano chromium picolinate (nCrPic) on metabolic responses of sheep to an intravenous glucose tolerance test (IVGTT), an intravenous insulin tolerance test (ITT) and an intramuscular adrenocorticotropin hormone (ACTH) challenge in sheep. Thirty-six sheep housed in metabolic cages were randomly allocated within 3 dietary groups (0, 400 and 800 μg/kg supplemental nCrPic) to either thermoneutral (22 °C) or cyclic HS (22 to 40 °C) conditions for 3 wk. Basal plasma glucose tended to be increased during HS (P = 0.052) and decreased by dietary nCrPic (P = 0.013) while plasma non-esterified fatty acid concentrations were decreased (P = 0.010) by HS. Dietary nCrPic reduced the plasma glucose area under the curve (P = 0.012) while there were no significant effects of HS on plasma glucose area under the curve in response to the IVGTT. The plasma insulin response over the first 60 min after the IVGTT was decreased by HS (P = 0.013) and dietary nCrPic (P = 0.022) with the effects being additive. In response to the ITT plasma glucose reached a nadir sooner (P = 0.005) in sheep exposed to HS, although there was no effect on the depth of the nadir. Dietary nCrPic decreased (P = 0.007) the plasma glucose nadir after ITT. Over the duration of the ITT plasma insulin concentrations were lower in sheep exposed to HS (P = 0.013) whereas there was no significant effect of supplemental nCrPic. There was no effect of either HS or nCrPic on cortisol response to ACTH. Dietary nCrPic supplementation decreased (P = 0.013) mitogen-activated protein kinase-8 (JNK) and increased (P = 0.050) carnitine palmitoyltransferase 1B (CPT1B) mRNA expression in skeletal muscle. Results of this experiment demonstrated that animals under HS and supplemented with nCrPic had greater insulin sensitivity

An Introduction to the ‘Oceans and Society: Blue Planet’ Initiative

We live on a blue planet, and Earth’s waters benefit many sectors of society. The future of our blue planet is increasingly reliant on the services delivered by marine, coastal and inland waters and on the advancement of effective, evidence-based decisions on sustainable development. ‘Oceans and Society: Blue Planet’ is an initiative of the Group on Earth Observations (GEO) that aims to ensure the sustained development and use of ocean and coastal observations for the benefit of society. The initiative works to advance and exploit synergies among the many observational programmes devoted to ocean and coastal waters; to improve engagement with a variety of stakeholders for enhancing the timeliness, quality and range of information delivered; and to raise awareness of the societal benefits of ocean observations at the public and policy levels. This paper summarises the role of the initiative, current activities and considerations for future directions

PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation

Abstract The role of PPM1D mutations in de novo gliomagenesis has not been systematically explored. Here we analyze whole genome sequences of 170 pediatric high-grade gliomas and find that truncating mutations in PPM1D that increase the stability of its phosphatase are clonal driver events in 11% of Diffuse Midline Gliomas (DMGs) and are enriched in primary pontine tumors. Through the development of DMG mouse models, we show that PPM1D mutations potentiate gliomagenesis and that PPM1D phosphatase activity is required for in vivo oncogenesis. Finally, we apply integrative phosphoproteomic and functional genomics assays and find that oncogenic effects of PPM1D truncation converge on regulators of cell cycle, DNA damage response, and p53 pathways, revealing therapeutic vulnerabilities including MDM2 inhibition